• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型半自动Hydragel 11血管性血友病因子多聚体检测试剂盒用于常规检测的评估。

Evaluation of a new semi-automated Hydragel 11 von Willebrand factor multimers assay kit for routine use.

作者信息

Pikta Marika, Szanto Timea, Viigimaa Margus, Lejniece Sandra, Balode Dārta, Saks Kadri, Banys Valdas

机构信息

North Estonia Medical Centre, Department of Laboratory Medicine, Tallinn, Estonia.

Helsinki University Hospital Comprehensive Cancer Centre and University of Helsinki, Coagulation Disorders Unit, Department of Hematology, Helsinki, Finland.

出版信息

J Med Biochem. 2021 Mar 12;40(2):167-172. doi: 10.5937/jomb0-26008.

DOI:10.5937/jomb0-26008
PMID:33776566
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7982284/
Abstract

BACKGROUND

Accurate diagnosis and classification of von Willebrand disease (VWD) are essential for optimal management. The von Willebrand factor multimers analysis (VWF:MM) is an integral part of the diagnostic process in the phenotypic classification, especially in discrepant cases. The aim of this study was to evaluate the performance of a new Hydragel 11VWF multimer assay (H11VW).

METHODS

Analytical performance characteristics such as repeatability (intra-assay variability, in gel between track variation), reproducibility (inter-assay variability, between gel variation), sensitivity, EQA performance and differences between two commercially available VWF:MM kits (H5VW and H11VW) were analysed in healthy volunteers' plasmas using in-house prepared reference plasma.

RESULTS

Repeatability and reproducibility results of H11VW demonstrated acceptable and equivalent performance with previously verified H5VW. Participation in EQA was successful. No statistically significant difference was detected between H5VW and H11VW kits for different fractions of multimers: LMWM p=0.807; IMWM p=0.183; HMWM p=0.774.

CONCLUSIONS

H11VW demonstrated acceptable analytical performance characteristics. H11VW kit conveniently offers a more significant number of samples on a single gel. H5VW and H11VW kits can be used in daily practice interchangeably.

摘要

背景

准确诊断和分类血管性血友病(VWD)对于优化治疗至关重要。血管性血友病因子多聚体分析(VWF:MM)是表型分类诊断过程的一个组成部分,尤其是在存在差异的病例中。本研究的目的是评估新型Hydragel 11VWF多聚体检测法(H11VW)的性能。

方法

使用内部制备的参考血浆,在健康志愿者血浆中分析H11VW的分析性能特征,如重复性(批内变异、凝胶内泳道间变异)、再现性(批间变异、凝胶间变异)、灵敏度、EQA性能以及两种市售VWF:MM试剂盒(H5VW和H11VW)之间的差异。

结果

H11VW的重复性和再现性结果显示出与先前验证的H5VW相当且可接受的性能。成功参与了EQA。H5VW和H11VW试剂盒在不同多聚体组分方面未检测到统计学上的显著差异:低分子量多聚体p = 0.807;中分子量多聚体p = 0.183;高分子量多聚体p = 0.774。

结论

H11VW表现出可接受的分析性能特征。H11VW试剂盒在单块凝胶上能方便地检测更多样本。H5VW和H11VW试剂盒在日常实践中可互换使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee85/7982284/d42a12b33f26/jomb-40-2-2102167P-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee85/7982284/428364e58b64/jomb-40-2-2102167P-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee85/7982284/d42a12b33f26/jomb-40-2-2102167P-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee85/7982284/428364e58b64/jomb-40-2-2102167P-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee85/7982284/d42a12b33f26/jomb-40-2-2102167P-g002.jpg

相似文献

1
Evaluation of a new semi-automated Hydragel 11 von Willebrand factor multimers assay kit for routine use.一种新型半自动Hydragel 11血管性血友病因子多聚体检测试剂盒用于常规检测的评估。
J Med Biochem. 2021 Mar 12;40(2):167-172. doi: 10.5937/jomb0-26008.
2
Semi-automated von Willebrand factor multimer assay for von Willebrand disease: Further validation, benefits and limitations.半自动化 von Willebrand 因子多聚体分析检测 von Willebrand 病:进一步验证、获益及局限性。
Int J Lab Hematol. 2019 Dec;41(6):762-771. doi: 10.1111/ijlh.13107. Epub 2019 Sep 11.
3
Investigation of von Willebrand factor multimer abnormalities before and after aortic valve replacement using the Hydragel-5 assay.应用 Hydragel-5 assay 研究主动脉瓣置换术前及术后血管性血友病因子多聚体异常
Thromb Res. 2024 Sep;241:109094. doi: 10.1016/j.thromres.2024.109094. Epub 2024 Jul 6.
4
Evaluation of a semi-automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers.两个欧洲中心对一种半自动血管性血友病因子多聚体检测方法——Hydragel 5血管性血友病多聚体检测法进行的评估。
Res Pract Thromb Haemost. 2018 Aug 12;2(4):790-799. doi: 10.1002/rth2.12141. eCollection 2018 Oct.
5
Establishing reference intervals for von Willebrand factor multimers.建立血管性血友病因子多聚体的参考区间。
J Med Biochem. 2022 Feb 2;41(1):115-121. doi: 10.5937/jomb0-31941.
6
Preclinical evaluation of a semi-automated and rapid commercial electrophoresis assay for von Willebrand factor multimers.一种用于血管性血友病因子多聚体的半自动快速商业电泳分析方法的临床前评估
J Clin Lab Anal. 2018 Jul;32(6):e22416. doi: 10.1002/jcla.22416. Epub 2018 Feb 17.
7
Comparative assessment of von Willebrand factor multimers vs activity for von Willebrand disease using modern contemporary methodologies.采用现代当代方法对血管性血友病因子多聚体与活性进行比较评估。
Haemophilia. 2020 May;26(3):503-512. doi: 10.1111/hae.13957. Epub 2020 Mar 11.
8
Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution.改善血管性血友病的诊断:血管性血友病因子多聚体分布的参考范围
Res Pract Thromb Haemost. 2020 Jul 16;4(6):1024-1034. doi: 10.1002/rth2.12408. eCollection 2020 Aug.
9
Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors.2A型和2B型血管性血友病变异体中血管性血友病因子寡聚体的不同组织形式:去氨加压素输注和蛋白酶抑制剂的作用
Ann Hematol. 1995 Oct;71(4):189-94. doi: 10.1007/BF01910317.
10
High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.高分辨率多聚体分析和PFA-100血小板功能分析仪能够在血管性血友病因子辅因子活性与血管性血友病因子抗原水平无病理比值的情况下检测出2A型血管性血友病。
Clin Lab. 2012;58(11-12):1203-9.

引用本文的文献

1
A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura.一种新型 von Willebrand 因子多聚体比值作为血栓性血小板减少性紫癜疾病活动的标志物。
Blood Adv. 2023 Sep 12;7(17):5091-5102. doi: 10.1182/bloodadvances.2023010028.
2
Establishing reference intervals for von Willebrand factor multimers.建立血管性血友病因子多聚体的参考区间。
J Med Biochem. 2022 Feb 2;41(1):115-121. doi: 10.5937/jomb0-31941.
3
Von Willebrand Factor Multimeric Assay in Acquired von Willebrand Disease Diagnosis: A Report of Experience from North Estonia Medical Centre.

本文引用的文献

1
Semi-automated von Willebrand factor multimer assay for von Willebrand disease: Further validation, benefits and limitations.半自动化 von Willebrand 因子多聚体分析检测 von Willebrand 病:进一步验证、获益及局限性。
Int J Lab Hematol. 2019 Dec;41(6):762-771. doi: 10.1111/ijlh.13107. Epub 2019 Sep 11.
2
Evaluation of a semi-automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers.两个欧洲中心对一种半自动血管性血友病因子多聚体检测方法——Hydragel 5血管性血友病多聚体检测法进行的评估。
Res Pract Thromb Haemost. 2018 Aug 12;2(4):790-799. doi: 10.1002/rth2.12141. eCollection 2018 Oct.
3
血管性血友病因子多聚体分析在获得性血管性血友病诊断中的应用:爱沙尼亚北部医疗中心的经验报告
J Lab Physicians. 2021 Sep;13(3):195-201. doi: 10.1055/s-0041-1730818. Epub 2021 Jun 28.
Evaluation of a new commercial method for von Willebrand factor multimeric analysis.
一种用于血管性血友病因子多聚体分析的新型商业方法的评估
Int J Lab Hematol. 2018 Oct;40(5):586-591. doi: 10.1111/ijlh.12869. Epub 2018 Jun 19.
4
Preclinical evaluation of a semi-automated and rapid commercial electrophoresis assay for von Willebrand factor multimers.一种用于血管性血友病因子多聚体的半自动快速商业电泳分析方法的临床前评估
J Clin Lab Anal. 2018 Jul;32(6):e22416. doi: 10.1002/jcla.22416. Epub 2018 Feb 17.
5
Comprehensive re-evaluation of historical von Willebrand disease diagnosis in association with whole blood platelet aggregation and function.结合全血血小板聚集和功能对历史 von Willebrand 病诊断进行全面再评估。
Int J Lab Hematol. 2018 Jun;40(3):304-311. doi: 10.1111/ijlh.12785. Epub 2018 Feb 10.
6
Laboratory Testing for Von Willebrand Factor Multimers.血管性血友病因子多聚体的实验室检测
Methods Mol Biol. 2017;1646:495-511. doi: 10.1007/978-1-4939-7196-1_36.
7
Evaluation of a new commercial von Willebrand factor multimer assay.一种新型商用血管性血友病因子多聚体检测方法的评估
Haemophilia. 2017 Jul;23(4):e373-e377. doi: 10.1111/hae.13261. Epub 2017 May 12.
8
Laboratory diagnosis of von Willebrand disease.血管性血友病的实验室诊断
Int J Lab Hematol. 2015 May;37 Suppl 1(Suppl 1):11-7. doi: 10.1111/ijlh.12345.
9
Clinical measurement of von Willebrand factor by fluorescence correlation spectroscopy.荧光相关光谱法测定血管性血友病因子。
Clin Chem. 2012 Jun;58(6):1010-8. doi: 10.1373/clinchem.2011.179200. Epub 2012 Mar 26.
10
Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder.血管性血友病:一种全球分布的出血性疾病的局部诊断和管理。
Semin Thromb Hemost. 2011 Jul;37(5):440-55. doi: 10.1055/s-0031-1281028. Epub 2011 Nov 18.